| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 45.2584 | 28 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.2785 | 33 |
| GSM780709 | Untreated after 4 days (C3_1) | 49.5814 | 47 |
| GSM780719 | Untreated after 4 days (C1_2) | 47.8315 | 40 |
| GSM780720 | Untreated after 4 days (C2_2) | 51.2624 | 52 |
| GSM780721 | Untreated after 4 days (C3_2) | 47.2337 | 38 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 51.7233 | 53 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 50.0192 | 49 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 50.381 | 50 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 51.6835 | 53 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 52.3005 | 55 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 47.4336 | 39 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 50.2222 | 49 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 39.2059 | 5 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 42.5337 | 15 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 50.2084 | 49 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 46.419 | 34 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 53.7628 | 58 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 46.4361 | 34 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 47.7969 | 40 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 48.7019 | 44 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.0505 | 37 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 51.0559 | 52 |